We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$847M
AUM Growth
+$73.3M
Cap. Flow
+$24.4M
Cap. Flow %
2.88%
Top 10 Hldgs %
61.2%
Holding
102
New
12
Increased
20
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$4.8M
2
AGN
Allergan plc
AGN
+$3.43M
3
ESRX
Express Scripts Holding Company
ESRX
+$2.3M
4
CELG
Celgene Corp
CELG
+$1.64M
5
GE icon
GE Aerospace
GE
+$1.5M

Top Sells

Rank Stock Value
1
OCRX
Ocera Therapeutics, Inc.
OCRX
+$771K
2
BMY icon
Bristol-Myers Squibb
BMY
+$450K

Sector Composition

Rank Sector Weight
1 Financials 39.48%
2 Healthcare 24.74%
3 Industrials 10.63%
4 Technology 10.11%
5 Energy 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.11T
$211M 24.92%
709
+5
+0.7% +$1.42M
WFC icon
2
Wells Fargo
WFC
$264B
$93.7M 11.06%
1,544,420
– –
IBM icon
3
IBM
IBM
$225B
$46.7M 5.52%
318,507
+4,498
+1% +$654K
MMM icon
4
3M
MMM
$94.4B
$27M 3.18%
137,038
+2,249
+2% +$433K
JNJ icon
5
Johnson & Johnson
JNJ
$626B
$24.9M 2.94%
177,890
+3,960
+2% +$552K
DVA icon
6
DaVita
DVA
$11.4B
$24.1M 2.85%
333,920
+21,620
+7% +$1.33M
PSX icon
7
Phillips 66
PSX
$89.5B
$23.5M 2.78%
232,600
+6,100
+3% +$580K
PX
8
DELISTED
Praxair Inc
PX
$23.5M 2.77%
151,740
+720
+0.5% +$107K
NVO
9
Novo Nordisk
NVO
$207B
$22.7M 2.69%
847,600
– –
RTX icon
10
RTX Corp
RTX
$302B
$21.1M 2.5%
263,218
+7,707
+3% +$585K
DHR icon
11
Danaher
DHR
$146B
$20M 2.37%
243,422
– –
V icon
12
Visa
V
$677B
$19.6M 2.31%
171,900
– –
POT
13
DELISTED
Potash Corp Of Saskatchewan
POT
$19.4M 2.29%
940,900
– –
BA icon
14
Boeing
BA
$184B
$19M 2.24%
64,300
– –
ROP icon
15
Roper Technologies
ROP
$39.5B
$18.4M 2.17%
71,020
+420
+0.6% +$108K
WAB icon
16
Wabtec
WAB
$50.3B
$15.7M 1.85%
192,770
+9,470
+5% +$724K
AGN
17
DELISTED
Allergan plc
AGN
$14.8M 1.75%
90,500
+19,100
+27% +$3.43M
NOV icon
18
NOV
NOV
$7.49B
$12M 1.42%
333,800
– –
GILD icon
19
Gilead Sciences
GILD
$168B
$10.6M 1.25%
147,930
+6,000
+4% +$456K
FTV icon
20
Fortive
FTV
$18.6B
$10.3M 1.21%
224,703
– –
AMGN icon
21
Amgen
AMGN
$224B
$10.1M 1.19%
57,970
– –
ESRX
22
DELISTED
Express Scripts Holding Company
ESRX
$10M 1.19%
134,600
+36,040
+37% +$2.3M
WAT icon
23
Waters Corp
WAT
$40.7B
$10M 1.18%
51,800
– –
ISRG icon
24
Intuitive Surgical
ISRG
$142B
$8.51M 1%
69,930
– –
CELG
25
DELISTED
Celgene Corp
CELG
$7.51M 0.89%
71,970
+14,570
+25% +$1.64M
1
2 3 4

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q4 2017 Portfolio in Review

As of Q4 2017, Hikari Power held 102 positions worth $847M, up 9.5% from $774M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power's Q4 2017 filing shows 12 new, 20 increased, 2 reduced and 1 closed positions. Its largest new stake was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares): 129,200 shares worth $5.21M. The largest sale was Ocera Therapeutics, Inc., an estimated $771K.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q4 2017 buy was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares): 129,200 shares worth $5.21M.
  • Hikari Power added most to Allergan plc in Q4 2017, an estimated $3.43M increase.
  • Hikari Power's biggest Q4 2017 reduction was Bristol-Myers Squibb, cutting an estimated $450K.
  • Hikari Power fully exited Ocera Therapeutics, Inc. in Q4 2017, selling an estimated $771K.
  • Hikari Power's ten largest holdings make up 61% of its $847M portfolio in Q4 2017.
  • Hikari Power opened 12 new positions and closed 1 in Q4 2017.
  • Hikari Power's portfolio value rose 9.5% quarter-over-quarter to $847M.

Based on Hikari Power's 13F filing for Q4 2017, filed 12 Jan 2018.